Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proof-of-concept randomized trial of tafoxiparin for cervical ripening in labor induction
2019-000620-17Phase 2Completed
- Sponsor
- Dilafor AB
- Start
- Mar 2019
- Modality
- Bivalent/Multivalent Binders → Multivalent & Scaffold-Based Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in induced labor comparing Tafoxiparin with Placebo (2 arms). Primary endpoint: Primary: Cervical ripening rate. Started Mar 2019; status: completed.
02
Drugs
tafoxiparin
03
Conditions
induced labor
Beyond the preview
Go deeper on 2019-000620-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-000620-17.